1: Mitscher LA, Swayze JK, Högberg T, Khanna I, Rao GS, Theriault RJ, Kohl W, Hanson C, Egan R. Biosynthesis of cetocycline. J Antibiot (Tokyo). 1983 Oct;36(10):1405-7. doi: 10.7164/antibiotics.36.1405. PMID: 6643286.
2: Proctor R, Craig W, Kunin C. Cetocycline, tetracycline analog: in vitro studies of antimicrobial activity, serum binding, lipid solubility, and uptake by bacteria. Antimicrob Agents Chemother. 1978 Apr;13(4):598-604. doi: 10.1128/aac.13.4.598. PMID: 666291; PMCID: PMC352294.
3: Theriault RJ, Guagliardi L, Hudson PB, Mitscher LA, Park YH, Swayze JK. Microbiological conversion of 4-epi-cetocycline to 2-decarboxamido-2-acetyl-4-dedimethyl-9-methyltetracycline. J Antibiot (Tokyo). 1982 Mar;35(3):364-6. doi: 10.7164/antibiotics.35.364. PMID: 7076581.
4: Grandclaudon C, Birudukota NVS, Elgaher WAM, Jumde RP, Yahiaoui S, Arisetti N, Hennessen F, Hüttel S, Stadler M, Herrmann J, Miethke M, Hartmann RW, Müller R, Hirsch AKH, Brönstrup M. Semisynthesis and biological evaluation of amidochelocardin derivatives as broad-spectrum antibiotics. Eur J Med Chem. 2020 Feb 15;188:112005. doi: 10.1016/j.ejmech.2019.112005. Epub 2019 Dec 20. PMID: 31911294.
5: Lukežič T, Fayad AA, Bader C, Harmrolfs K, Bartuli J, Groß S, Lešnik U, Hennessen F, Herrmann J, Pikl Š, Petković H, Müller R. Engineering Atypical Tetracycline Formation in Amycolatopsis sulphurea for the Production of Modified Chelocardin Antibiotics. ACS Chem Biol. 2019 Mar 15;14(3):468-477. doi: 10.1021/acschembio.8b01125. Epub 2019 Feb 12. PMID: 30747520.
6: Herrmann J, Lukežič T, Kling A, Baumann S, Hüttel S, Petković H, Müller R. Strategies for the Discovery and Development of New Antibiotics from Natural Products: Three Case Studies. Curr Top Microbiol Immunol. 2016;398:339-363. doi: 10.1007/82_2016_498. PMID: 27738913.
7: Stepanek JJ, Lukežič T, Teichert I, Petković H, Bandow JE. Dual mechanism of action of the atypical tetracycline chelocardin. Biochim Biophys Acta. 2016 Jun;1864(6):645-654. doi: 10.1016/j.bbapap.2016.03.004. Epub 2016 Mar 9. PMID: 26969785.
8: Chopra I. Tetracycline analogs whose primary target is not the bacterial ribosome. Antimicrob Agents Chemother. 1994 Apr;38(4):637-40. doi: 10.1128/aac.38.4.637. PMID: 8031024; PMCID: PMC284517.
9: Kornguth ML, Kunin CM. Minocycline-induced loss of potassium from erythrocytes: identification of a family with an augmented response. J Infect Dis. 1978 Oct;138(4):455-62. doi: 10.1093/infdis/138.4.455. PMID: 152337.
10: Hennessen F, Miethke M, Zaburannyi N, Loose M, Lukežič T, Bernecker S, Hüttel S, Jansen R, Schmiedel J, Fritzenwanker M, Imirzalioglu C, Vogel J, Westermann AJ, Hesterkamp T, Stadler M, Wagenlehner F, Petković H, Herrmann J, Müller R. Amidochelocardin Overcomes Resistance Mechanisms Exerted on Tetracyclines and Natural Chelocardin. Antibiotics (Basel). 2020 Sep 18;9(9):619. doi: 10.3390/antibiotics9090619. PMID: 32962088; PMCID: PMC7559539.